There is more competition in play for Emgality from Lundbeck’s new intravenous CGRP drug Vyepti (eptinezumab), which requires less frequent dosing of Emgality as well as Aimovig and Ajovy ...

In the ACHIEVE II study published in JAMA, ubrogepant at both 25 mg and 50 mg doses was more effective than placebo at ridding patients of pain two hours after dosing, while the higher dose was ...

The prescribed dosage for fluoxetine may depend on a person’s individual treatment plan. Other factors, including your specific diagnosis, body weight, and medical history, may affect your ...

Dosing a statin (rosuvastatin) every other day (EOD) may provide significant lipoprotein changes while avoiding common adverse effects in this statin-intolerant population. Objective: To determine ...

There is insufficient scientific evidence to establish a safe or effective dose of DMAE. Always speak with a healthcare provider before taking a supplement to ensure that the supplement and dosage are ...